naut: the income statement

MyFinsight

Nautilus Biotechnology, Inc. (NAUT)

For the quarter ending 2025-06-30, NAUT made $2,080K in revenue. -$15,033K in net income. Net profit margin of -722.74%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	10,394
General and administrative	6,703
Total operating expenses	17,097
Other expense	16
Interest income	2,080
Total other income	2,064
Net loss	-15,033

Net loss per share attributable to common stockholders, basic (in dollars per share)	-0.12
Net loss per share attributable to common stockholders, diluted (in dollars per share)	-0.12
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	126,204,632
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	126,204,632

Unit: Thousand (K) dollars (except for numbers of shares and EPS)